UK equities staged a recovery on Thursday, with the blue-chip FTSE 100 up 1.66% at closing, tracking a widespread rise in European shares.
Markets are awaiting the release of the final June 2026 services PMI data on Friday. The flash estimate showed the services PMI falling to 48.7 from 49.3 in May 2026, marking its lowest reading since January 2023 and indicating a second straight month of contraction.
Meanwhile, results of the Business Insights and Conditions Survey in June showed that the number of businesses concerned about the potential impact of international conflict on supply chains over the next year decreased to 31% from 38% in April. Businesses with at least 10 employees responded to the survey, according to the UK's Office for National Statistics.
In geopolitical news, the US and Iran concluded another round of technical talks in Doha, with mediators reporting progress on measures to support a longer-term peace agreement and restore shipping through the Strait of Hormuz. Qatar's Foreign Ministry said the next round of talks will resume following Iran's late Supreme Leader Ayatollah Ali Khamenei's state funeral.
On the corporate front, AstraZeneca (AZN.L) gained 4.94% after entering a partnership with China's CSPC Pharmaceutical Group to develop novel small nucleic acid drug candidates using the latter's siRNA drug discovery and extrahepatic targeted delivery platforms. AstraZeneca will have the option to obtain exclusive rights for each preclinical candidate globally or outside of China.
Coca-Cola Europacific Partners (CCEP.L) edged up 0.44% after saying it plans to launch next week the second tranche of its share buyback program of up to 500 million pounds sterling. The buyback is part of its proposal to return 1 billion pounds to shareholders through share repurchases.